Anders Krüger

Anders Krüger is an accomplished finance executive with extensive international experience in various high-level finance roles. Currently serving as VP, Head of TDS and Thrombosis Finance at LEO Pharma, Krüger has held pivotal positions, including VP Global Accounting, Controlling and Tax at the same company, and VP, CFO roles at Takeda Pharmaceuticals, overseeing finance operations across multiple global territories. Krüger's expertise encompasses strategic finance, M&A support, post-merger integration, and finance transformation across leading companies such as Nycomed Group, CP Kelco, and Hyperion Solutions Nordic. Additionally, Krüger has contributed to the Danish Swiss Chamber of Commerce as a board member and has provided independent CFO consulting services through Krüger CFO Services Consulting. Educational credentials include a Master of Science in Business Economics and Auditing and a Bachelor in Financial Management and Accounting from Copenhagen Business School.